Story thread · 2 reports / 2 sources
Despite Medicare Coverage, Cancer Genomic Testing Still Low
medscape.com · 12d
Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low. Medscape Medical News
First report: A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati — thehindu.com, 14d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.